| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 05/13/2004 | US20040091742 Naphthalocyanine based charge generating materials; photo-receptor, photoconductive, optical recording, solar cell and/or nonlinear optical materials; synthesis |
| 05/13/2004 | US20040091426 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
| 05/13/2004 | US20040088801 Novel pyrazolo-triazoles and use of said compounds for dyeing keratinous fibres |
| 05/13/2004 | DE10250080A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments |
| 05/13/2004 | CA2503786A1 Compounds having both alpha7 nicotinic agonist activity and 5ht, antagonist activity for treatment of cns diseases |
| 05/13/2004 | CA2503119A1 Anti-infective biaryl compounds |
| 05/13/2004 | CA2485343A1 Mitotic kinesin inhibitors |
| 05/12/2004 | EP1418207A1 Mu-oxo bridged heterometal compound and selective production method thereof |
| 05/12/2004 | EP1417207A2 Process for preparing 2-(4-pyridyl) amino-6-dialkyloxyphenyl-pyrido(2,3-d)pyrimidin-7-ones |
| 05/12/2004 | EP1417190A1 Substituted piperazines as modulators of the melanocortin receptor |
| 05/12/2004 | EP1417162A1 Chromatographic separation of enantiomers of protected amino acids via smb-method |
| 05/12/2004 | EP1416935A1 4-amino-6-phenyl-pyrrolo 2,3-d]pyrimidine derivatives |
| 05/12/2004 | EP1416929A2 Cancer treatment with gö6976 and its related compounds |
| 05/12/2004 | EP1030645B1 Oxidation dyeing composition for keratinous fibres and dyeing method using same |
| 05/12/2004 | EP1018514B1 NF-$g(k)B INHIBITORS CONTAINING INDAN DERIVATIVES AS THE ACTIVE INGREDIENT |
| 05/12/2004 | EP1015429B1 Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor xa |
| 05/12/2004 | EP0927192B1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 05/12/2004 | CN1496362A Non-imidazole compounds as histamine H3 antagonists |
| 05/12/2004 | CN1496262A Triazolo [4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonists |
| 05/12/2004 | CN1496259A New use |
| 05/12/2004 | CN1495908A Molecular device and array, rectifier and method, sensor and relative device |
| 05/12/2004 | CN1495185A Improving method for preparing cross-bridge macrocylic compound |
| 05/12/2004 | CN1495172A Irreversible inhibitor of tyrosine kinase |
| 05/12/2004 | CN1495169A Pyridine-3-carboxylic acid derivative |
| 05/12/2004 | CN1494906A Application of compound in preparation of medicine for preventing and curing multiple drug resistance |
| 05/12/2004 | CN1149214C Triazolo gerivatives and chemokine inhibitors containing the same as the active ingredient |
| 05/12/2004 | CN1149213C Substituted benzoylisoxazoles and the use thereof as herbicides |
| 05/12/2004 | CN1149206C Intermediate compound for preparing xibo ketone |
| 05/12/2004 | CN1149196C Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 05/12/2004 | CN1149101C Green porphyrins as immunomodulators |
| 05/12/2004 | CN1149065C Dyeing composition containing pyrazolo-[1,5-alpha]-pyrimidine as oxidation base and pyridine coupling agent, dyeing method |
| 05/12/2004 | CN1149064C Oxidation dyeing composition for keratinous fibres and dyeing method using same |
| 05/11/2004 | US6734306 N-benzenesulfonyl L-proline compounds as bradykinin antagonists |
| 05/11/2004 | US6734301 2,3,4,5-Tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds |
| 05/11/2004 | US6734186 Phosphodiesterase 2 inhibitor |
| 05/11/2004 | US6734185 Pyrrolo[3,4-d]pyrimidines as corticotropin releasing factor (CRF) antagonists |
| 05/11/2004 | US6734181 Gastric acid secretory inhibition activity, gastric mucous membrane protection activity; treatment of ulcers and helicobacter pylori infecions |
| 05/11/2004 | US6734180 NF-κB inhibitor comprising an indan derivative as an active ingredient |
| 05/11/2004 | US6733982 Method for screening compounds for alpha1B adrenergic receptor antagonist and analgesic activity |
| 05/11/2004 | CA2184411C Process for preparing polymorphs b and c of 1-[2,4-dichloro-.beta.-[(7-chlorobenzo[b]thien-3-yl)methoxy]phenethyl]imidazole mononitrate |
| 05/06/2004 | WO2004037831A1 Novel substituted[1,4]benzodioxino[2,3-e]isoindole derivatives, method for preparing same and pharmaceutical compositions containing same |
| 05/06/2004 | WO2004037825A1 Hexadecaazanaphthalo cyanine compound and polymer thereof |
| 05/06/2004 | WO2004037824A1 Process for the preparation of zaleplon |
| 05/06/2004 | WO2004037810A1 Selected cgrp antagonists, method for production and use thereof as medicament |
| 05/06/2004 | WO2004037800A1 Aryloxyalkylamine derivates as h3 receptor ligands |
| 05/06/2004 | WO2004037212A2 Compositions comprising zopiclone derivatives and methods of making and using the same |
| 05/06/2004 | WO2004016614A3 Pyrrolopyrazines as kinase inhibitors |
| 05/06/2004 | WO2003050082A3 Regioisomerically pure oxochlorins and methods of synthesis |
| 05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/06/2004 | WO2002088078A3 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3β PROTEIN AND PROTEIN COMPLEXES |
| 05/06/2004 | US20040087800 Spirooxindole derivatives are analgesics for the treatment of chronic pain. |
| 05/06/2004 | US20040087639 6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which provide analgesia |
| 05/06/2004 | US20040087627 Decarboxylase inhibitors; cardiovascular diosrders; antidiabetic agents; anticancer agents; dietetics |
| 05/06/2004 | US20040087616 1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease |
| 05/06/2004 | US20040087600 Amino-substituted dihydropyrimido[4,5-D]pyrimidinone derivatives |
| 05/06/2004 | US20040087599 cGMP-PDE inhibitors for the treatment of erectile dysfunction |
| 05/06/2004 | US20040087598 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-1,3-dihydoimidazo{1,2-a}pyrimidin-5(1h)one derivatives |
| 05/06/2004 | US20040087591 Phosphodiesterase inhibitors and nitric oxide donors, compositions and methods of use |
| 05/06/2004 | US20040087589 Controlling elimination of corticotropin releasing factor; stroke therapy |
| 05/06/2004 | US20040087588 Parp inhibitors |
| 05/06/2004 | US20040087581 Heterocyclylalkylamines as muscarinic receptor antagonists |
| 05/06/2004 | US20040087568 Substituted anthranilic amide derivatives and methods of use |
| 05/06/2004 | US20040087552 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/06/2004 | US20040087548 Anticancer agents and treating immune disorders |
| 05/06/2004 | US20040086851 Anticancer agents |
| 05/06/2004 | EP1416017A1 Fluorescent nucleosides, nucleotides or polynucleotides containing a rhodamine dye |
| 05/06/2004 | EP1415992A1 Diamine derivatives |
| 05/06/2004 | EP1415987A1 Nitrogenous aromatic ring compounds |
| 05/06/2004 | EP1414823A1 Novel materials for selective trapping of carbon monoxide |
| 05/06/2004 | EP1414795A1 Bicyclic modulators of androgen receptor function |
| 05/06/2004 | EP1414464A2 Method for treating glaucoma v |
| 05/06/2004 | EP1414302A1 7-amino triazolopyrimidines for controlling harmful fungi |
| 05/06/2004 | EP1325011B1 Methods and compounds for treating proliferative diseases |
| 05/06/2004 | EP1060181B1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| 05/06/2004 | EP0998476B1 1,4,7,10-tetraazabicyclo 8.2.2]tetradecan-2-one, a process for the preparation thereof and the use thereof for the preparation of tetraazamacrocycles |
| 05/06/2004 | CA2503455A1 Selected cgrp antagonists, method for production and use thereof as medicament |
| 05/06/2004 | CA2503152A1 Process for the preparation of zaleplon |
| 05/06/2004 | CA2502488A1 Novel substituted[1,4]benzodioxino[2,3-e]isoindole derivatives, method for preparing same and pharmaceutical compositions containing same |
| 05/05/2004 | CN1493291A Dicyclic compound capable of inhibiting epidermis growth factor acceptor rotatory tyrosine kinase |
| 05/05/2004 | CN1148360C Intermediate for preparing cascade polymeric ligand usable as contrast medium |
| 05/04/2004 | US6730786 Process for the preparation of pyrazolopyrimidinones |
| 05/04/2004 | US6730690 Delaying the onset or reducing the risk of developing atherosclerosis in a human patient comprising administering to said patient an effective amount of a compound of invention and an hmg-coa reductase inhibitor |
| 05/04/2004 | US6730681 Anxiolytic agents and anticonvulsants |
| 05/04/2004 | US6730680 6-phenyl-pyrazolopyrimidines |
| 05/04/2004 | US6730676 Central nervous system disorders; cognition activators |
| 05/04/2004 | US6730675 Such as 7-chloro-4-hydroxy-2-(2,5-dimethyl(3-furanyl)) methyl-1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-dione which binds nmda receptors (n-methyl-aspartic acid receptors); neuropathy |
| 05/04/2004 | US6730668 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 05/04/2004 | US6730666 Inhibition of growth factor tyrosine kinase receptor activity, particularly inhibition of angiogenesis and related disorders, tumor progression and growth factor related skeletal disorders, by porphyrin and corrole compounds |
| 04/29/2004 | WO2004035590A2 Meso-substituted porphyrins |
| 04/29/2004 | WO2004035589A1 Heterocyclocarboxamide derivatives |
| 04/29/2004 | WO2004035588A1 Pyradazine compounds as gsk-3 inhibitors |
| 04/29/2004 | WO2004035587A1 Reverse-turn mimetics and composition and methods relating thereto |
| 04/29/2004 | WO2004035586A1 Pyrrolo[1,2-b]pyridazine compounds and their uses |
| 04/29/2004 | WO2004035585A1 Synthesis of zaleplon |
| 04/29/2004 | WO2004035584A1 Pharmaceutical compounds specifically inhibiting smooth muscle pde5, pharmaceutical compositions containing same and therapeutic uses thereof |
| 04/29/2004 | WO2004035582A1 Pyrrolo (3,4-c) carbazole and pyrido (2,3-b) pyrrolo (3,4-e) indole derivatives, preparation method and pharmaceutical compositions containing same |
| 04/29/2004 | WO2004035580A1 Reactivation of wild type p53 in human tumour cells by a low molecular weight compound |
| 04/29/2004 | WO2004035577A2 Pre-organized tricyclic integrase inhibitor compounds |
| 04/29/2004 | WO2004035576A2 Pre-organized tricyclic integrase inhibitor compounds |
| 04/29/2004 | WO2004035556A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |